Michael J. Silverberg, PhD, MPH

Michael J. Silverberg, PhD, MPH Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3801 (phone)
michael.j.silverberg@kp.org

Michael J. Silverberg, PhD, MPH, has been a research scientist at the Division of Research, Kaiser Permanente Northern California since 2004. He received his doctorate in epidemiology from the Johns Hopkins University, Bloomberg School of Public Health in 2001, and his master’s in public health in epidemiology from the School of Public Health, University of California, Los Angeles in 1999.

Current Position(s):

Research Scientist II, Division of Research, Kaiser Permanente Northern California

Primary Research Interests:

Malignancies in HIV patients
HIV and cardiovascular complications.
Racial/ethnic differences in HIV care
Infectious disease epidemiology

HPV-Related Outcomes in Kaiser Permanente Patients: Trends Following Vaccine Dissemination

This study’s objective is to provide periodic population-based estimates of prespecified HPV-related clinical outcomes following the licensing and dissemination of the HPV vaccine.
Funder: Centers for Disease Control and Prevention
Principal Investigator: Silverberg, Michael

Prognostic Markers for HIV-related Diffuse Large B-Cell Lymphoma

This retrospective cohort study aims to investigate the prognostic significance of several viral and molecular factors for HIV-related diffuse large B-cell lymphoma (DLBCL) to advance clinical care and provide insight for new molecular therapeutic targets for DLBCL.
Funder: National Cancer Institute
Principal Investigator: Silverberg, Michael

Human Papaillomavirus Vaccine Impact Monitoring Through Surveillance of Cervical Precancerous Lesions

This retrospective cohort study of all women in Alameda County monitors the impact of the HPV vaccine on cervical cancer precursor lesions.
Funder: CDC Foundation
Principal Investigator: Silverberg, Michael

Patient Portal to Support Treatment Adherence in HIV Patients

This project includes observational studies describing electronic medical record use and the association with adherence in HIV patients. The observational studies will be followed by a randomized clinical trial to develop and field test a health information technology delivered behavioral intervention to increase adherence to antiretroviral treatment among HIV patients.
Funder: National Institute of Mental Health
Principal Investigator: Silverberg, Michael

Surveillance for Clinical Adverse Events Among HIV-infected Patients Enrolled in Kaiser Permanente

This study establishes a surveillance system to monitor the incidence and risk factors for serious potential adverse events to antiretroviral therapy.
Funder: Pfizer
Principal Investigator: Silverberg, Michael

HIV Infection, Antiretroviral Therapy, Cancer Incidence and Progression

This project includes several research studies and uses a retrospective cohort study design to address questions related to the relationship of HIV infection, immunodeficiency, and cancer risk and progression.
Funder: Nat. Inst. of Allergy and Infectious Diseases
Principal Investigator: Silverberg, Michael

Kaiser Permanente Division of Research